Denmark's Bavarian Nordic said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its ...
Yesterday the US Food and Drug Administration (FDA) approved a freeze-dried formulation of Bavarian Nordic's mpox vaccine, ...
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS ...
A new report from GlobalData has raised concerns over the effectiveness of mpox vaccines for people living with HIV. Findings ...
This recent safety and effectiveness data regarding mpox vaccination with Jynneos is important and timely given the ongoing ...
By Medha Singh and Sukriti Gupta (Reuters) -European shares rebounded on Tuesday after touching a two-month low in the ...
Explore more
Several Democratic-led states have taken legal action against the Trump administration over its decision to retract $11 ...
European shares rebounded on Tuesday from a two-month low touched in the previous session, while the market braced for an ...
The US Food and Drug Administration (FDA) has approved the freeze-dried formulation of Bavarian Nordic’s smallpox and mpox vaccine in a move expected to provide flexibility in stockpiling the jab.
The Company has been contracted by the U.S Biomedical Advanced Research and Development Authority (BARDA) to develop and supply a freeze-dried version of JYNNEOS for stockpiling. Manufacturing under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results